By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Autoinjector devices (AIDs) can be used by anyone without medical training and are helpful for administering medications and antidotes quickly. They are therefore particularly practical for mass casualty management and emergencies.
An AID has a medication cartridge with an embedded needle for an injection that can be given subcutaneously or intramuscularly and is typically painless.
As a result of the AID’s gradual drug delivery over a substantial area of muscle, drug absorption is increased, and pharmacological effects are on par with intravenous administration.
The AID contains a medication cartridge with an integrated needle for injections under the skin or into muscles.
The Global Medical auto injector market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The latest Aidaptus auto-injector was launched by Owen Mumford. Aidaptus is a two-stage, spring-powered, single-use auto-injector with a base that can hold both prefilled glass syringes measuring 1.25 mL and 2.25 mL.
Additionally, it has self-adjusting plunger technology with stopper sensing that automatically adjusts to the various fill volumes and stopper locations in each syringe. This technology eliminates the need for additional spare components.
A range of drug viscosities can be accommodated by the auto-injector, which comes with two different spring strengths.
A straightforward and reliable user experience is offered by Aidaptus’ patient-centric design and automatic needle insertion.
In combination with the separate, two-phase needle insertion and medication administration, the stopper detecting technology lessens any impact forces on the syringe, reducing the danger of syringe breakages while in use.
Aidaptus offers confidence to users who are new to auto-injectors as well as those who experience needle anxiety due to a needle that is insulated before, during, and after use. With an audio notification at the beginning and finish of the procedure, it can help reassure users that the injection has been done successfully.
Also indicating the end of injection is a bright yellow plunger rod that can be seen through a sizable window in the device.A clear outer body with a color overwrap allowing quick selection of the window size is one base platform option for Aidaptus, while a traditional opaque housing option also exists.
Both options offer versatility for branding and customization, as well as options for market segmentation and life cycle management.
Its exceptional human factors engineering and sustainable design were employed throughout its development, and design for manufacture (DfM) principles were used to take into account ease of final assembly. This is shown in the product’s exceptionally compact nature.
